Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Funding
U.S. Government Considers Research Finance Rules
September 3rd, 2000
A new era of biotechnology economics that promises some scientists great wealth may cause conflicts of interest that affect patient safety and undermine medical research, experts say. At a U.S. National Institutes of Health conference held August 15, 2000, speakers said that researchers who have a financial interest in drug companies may bias medical findings, put patients at risk, and erode public trust in the integrity of health science. "If a crisis in confidence develops, if research subjects no longer feel safe, then medical research will grind to a halt," said Jane Henney, commissioner of the U.S. Food and Drug Administration. ...
Source: Medical Letter on the CDC & FDA (2000-09-03)
|
